Clinical trialNCT00950157CompletedInterventional

Testing the Effect of a Caution for Drugs Approved on Surrogate Outcomes Alone

SponsorWhite River Junction Veterans Affairs Medical CenterEnrollment2,944Risk Communication

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test whether cautions about the evidence, in this case an "open questions" statement, decreases enthusiasm for drugs that are approved on surrogate outcomes (compared to patient outcomes) alone.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Lisa M Schwartz, MD, MS
White River Junction Veterans Affairs Medical Center
Principal Investigator
clinicaltrials.gov ↗
Steven Woloshin, MD, MS
White River Junction Veterans Affairs Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2009
Primary completion: 31 Aug 2009
Completion: 30 Sept 2009
Last update posted: 7 Jun 2010
Registered enrollment: 2,944
Registry id: NCT00950157

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.